Fractyl’s patent portfolio

Intellectual Property


Fractyl’s products are protected by patents in the U.S. and elsewhere.

The Revita® System, either alone or in combinations with its accessories, kits, and procedures, may be protected by one or more of the following patents:

U.S. Patents

Patent Number Issue Date Title
11,166,761 Nov. 9, 2021 Injectate Delivery Devices, Systems, and Methods
10,959,774 April 13, 2021 Injectate Delivery Devices, Systems and Methods
10,869,718 March 30, 2021 Methods and Systems for Treating Diabetes and Related Diseases and Disorders
10,765,474 December 15, 2020 Injectate Delivery Devices, Systems and Methods
10,610,663 September 8, 2020 Systems, Devices and Methods for Performing Medical Procedures in the Intestine
10,349,998 July 16, 2019 Heat Ablation Systems, Devices and Methods for the Treatment of Tissue
9.757,535 September 12, 2017 Systems, Devices, and Methods for Performing Medical Procedures in the Intestine
9.844.641 December 19, 2017 Systems, Devices, and Methods for Performing Medical Procedures in the Intestine

 

Additional patents may be issued and pending in the U.S. and elsewhere.

You are now leaving the Fractyl.com website

You are leaving Fractyl’s main website to go to Fractyl’s U.K. site.

By selecting Continue you will be directed to Fractyl’s U.K. site. If you would like to remain on Fractyl’s main site, select the Cancel button.

ContinueCancel